St. Luke's Radiation Oncology Network is looking to fill the role of SLRON/08-2026/865 Director of Physics in Dublin. Apply today!

Gerry Hanna: IASLC Quiz Winner at WCLC25 / cancer, Fiona McDonald, Gerry Hanna, Houda Bahig, OncoDaily, Oncology, Sara Ramella, Stephen Liu, World

Drew Moghanaki and Gerry Hanna Discuss Survival and Toxicity of New Phase 3 Trial in LS-SCLC / cancer, Drew Moghanaki, Gerry Hanna, LS-SCLC, OncoDaily, Oncology

After years of lobbying from patients, the first ever national lung cancer screening program will roll out next month for people who have a significant history of smoking.

This document reviews the evidence supporting different imaging modalities and techniques used to evaluate patients with a history of lung cancer. It …

Gerry Hanna: Highly Impactful Opening Address at ESTRO 2025 / cancer, ESTRO 2025, Gerry Hanna, OncoDaily, Oncology

The novel hybrid automatic segmentation tool reported high accuracy and consistency over a validation set with challenging anatomical and imaging variations. This has promising applications in substru...

Accurate delineation of target volumes (TVs) and organs at risk (OARs) is a prerequisite for precise lung radiation therapy to produce optimal treatment plans [1]. TV delineation in lung cancer has hi...

Applications of laser-plasma accelerated protons in fundamental, applied and medical sciences crucially depend on the creation of stable collimated beams with high repetition rates. Here the authors d...

During 2000–20, NHS coverage of new drugs displaced more population health than it generated. Our results highlight the inherent trade-offs between individuals who directly benefit from new drugs and those who forgo health due to the reallocation of resources towards new drugs.

Nature Medicine asks leading researchers to name their top clinical trial for 2025, from gene therapies for prion disease and sickle-cell disease to digital tools for cancer and mental health.